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Introduction: This study compares the effectiveness and cost of trans-catheter verses surgical
closure of secundum atrial septum defect (ASD). ASD accounts for 10% of congenital cardiac
defects. Trans-catheter closure of secundum ASD is increasingly used as the primary intervention.
Surgical repair is advised in a proportion of secundum type defects which are unsuitable for
device closure.
Methods: We reviewed the clinical course of 176 patients who underwent closure of isolated
secundum ASD. The patients were assigned to either the device or surgical group depending upon
the treatment they received. Successful closure was assessed immediately after the procedure. The
following outcomes were studied: mortality, morbidity, hospital stay, and costs.
Results: Ninety five patients were in the surgical group and 81 patients were in the group
undergoing device closure. The median age was 14.0 years (range 1.1-61.0) for surgical group
and 24.0 years (range 0.5-68.0) for the device group. The mortality in both groups was 0. The
procedure success rate was 100% for the surgical group and 96.3% for the device group. The
complication rate was 13.7% for surgical group and 7.4% for the device group. The mean length
of hospital stay was 5.0 ± 2.7 days for surgical group and 3.0 ± 0.4 days for device group. The
procedure cost for surgery was found to be 12.3% lower than that of trans-catheter closure.
Conclusion: Successful closure is achieved by both methods. Trans-catheter closure results in
lower rate of complication and hospital stay but the cost of the procedure tends to be higher
than surgery.
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Introduction
Atrial septal defect (ASD) is a common form of congenital
heart disease accounting for approximately 10% of all
congenital cardiac defects.1 Surgical closure has been
for many years, the gold standard treatment for patients
with ASDs.2,3 In 1976 Mills and King reported the first
transcatheter closure of secundum ASD4, since then
transcatheter closure of secundum ASD has evolved over
the past few decades and is being increasingly used as the
primary intervention in recent years. Surgical repair has
been proven to be superior to medical treatment in ostium
primum and sinus venosus type ASDs, as well as in a
proportion of secundum type defects which are unsuitable
for device closure5, with a low operative mortality and high
long-term survival in middle-aged and elderly patients.6,7
The diagnosis and management of ASD in both pediatric
and adult populations have benefited greatly from
major advances over the last few years8 including 3
dimensional and intracardiac echocardiography, as well
as percutaneous device closure. Despite these advances,

ASDs remain “the most under diagnosed congenital heart
disease in the adult age group”, with age at diagnosis being
clearly linked to subsequent complications including the
late development of pulmonary hypertension and atrial
dysrhythmias.9
As part of the general evolution of techniques in cardiac
surgery, emphasis has been placed on shorter incisions
and other surgical methods proposed as “less” or as
“minimally” invasive techniques, including minimal
access, port access, robotics, video-assisted, etc.7,1012
Complete closure of ASDs has been achieved less
frequently with transcatheter techniques than with
surgery. On the other hand, surgery results in a significant
morbidity.13,14 However, there are no single regional and
national reports of comparisons of early results, closure
rates, mortality, morbidity, and complications between
patients treated with either transcatheter or surgical
closure of ASD performed at the same time and in the
same institution.
The purpose of this study was to compare the safety and
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efficacy of transcatheter device closure of secundum
ASD with concurrent surgical repair results in a single
institution.
Material and methods
Eligibility Criteria
We reviewed charts of 176 patients who were admitted
for closure of secundum ASD either by surgery or device
closure between June 2006 to July 2012 and returned
for early or late follow-up at the Aga Khan University
Hospital. The inclusion criteria for both groups consisted
of the presence of an isolated secundum ASD (diameter
of ≤33 mm for device group; while no limit for surgery
group), a left to right shunt with Qp/Qs ratio ≥ 1.5:1 or
patients with small defect but history of paradoxical
embolism. Excluded from the study were those who had
other types of ASD (foramen primum or sinus venosus)
or the presence of an additional cardiac malformation
[ventricular septal defect (VSD), tetralogy of Fallot,
pulmonary stenosis etc.)]amenable only by surgical repair.
Additional exclusion criteria for the percutaneous
closure group were patients with multiple defects
that were unsuitable by device closure or a defect too
close to the superior vena cava, atrioventricular valve,
coronary sinus or pulmonary veins (predictable failure of
interventional procedure).
Patients who met the inclusion criteria for both groups
were given an option for opting either procedure. They
were presented with the complications associated
with each procedure (intervention with a chance of
embolization and surgery with a higher rate of morbidity)
before they made their decision.
Operative Technique
Surgery
All surgical procedures were done using cardiopulmonary
bypass. The chest was opened by via median sternotomy.
After total cardiopulmonary bypass had been achieved
either cold blood or crystalloid cardioplegic solution was
given antegrade through the aortic root. The method used
to close the defect depended on its size and anatomical
type. Three patients (3.2%) underwent direct suture
closure while the rest were closed by autologous pericardial
patch with Prolene 5-0 suture.
Device Implantation
The occlusion device used was the Amplatzer Septal
Occluder. This was because it is the only FDA approved
available deice in our setting. All percutaneous closure
was done under general anesthesia. The right femoral vein
was accessed using a 7–8 Fr short sheath. Heparin was
administered to achieve an activated clotting time (ACT)
> 200 seconds at the time of device deployment along with
1 g cefazolin intravenously. Right heart catheterization was
performed to ensure the presence of normal pulmonary
vascular resistance. The defect was sized using a 34 mm
balloon. The balloon was then inflated with diluted
contrast until the left to right shunt ceases as observed
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by color flow Doppler TEE (flow occlusion). If the defect
had adequate rims (>5 mm), we selected a device 0–2
mm larger than the balloon stretched diameter. However,
if the superior/anterior rim was deficient (5–7 mm), we
selected a device 4 mm larger than the balloon stretched
diameter. Our choice for the device size depended on the
echocardiographic measurements of the defect (TEE).
In adults, a device about 4–6 mm larger than the twodimensional (2D) size by color Doppler while in children,
a device no more than 2 mm larger than the 2D size by
color Doppler was used. Device was deployed with guide
wire over the left upper pulmonary vein. Position of the
device was confirmed on fluoroscopy and TEE. Once the
position of the device was confirmed, it was released.
Outcomes
Patients who had surgical closure residual intraatrial shunting (significant >2 mm) was examined by
colour Doppler while patients who had device closure
a transesophageal echocardiogram (TTE) with color
Doppler was done immediately after the procedure.
In addition a chest radiograph, an ECG and a physical
examination was conducted in both groups within 24 h.
Primary Outcome
If death occurred any time after surgery.
Secondary Outcome
Presence of any complications such as residual shunt,
reintervention, arrhythmias requiring medications,
pericardial effusion, etc.
Statistical Analysis
Data was analyzed using the SPSS for Windows (version
19.0) and is expressed as mean, median and minimum
and maximum ranges where appropriate.
Cost Estimation
Cost per case was calculated based on total hospitalization
that was reflected on the bill that patient would have
paid, excluding any subvention. This means that it was
a true reflection of the actual cost of treatment. The cost
included hospital room charges, laboratory investigations,
pharmaceutical charges, clinician and anaesthesia
charges, facility and treatment charges, cost of surgery
(including cardiopulmonary bypass) or device and for
their respective length of stay. In doing so, we were able to
achieve a meaningful comparison of true costs incurred
by each patient for either of the methods, which was the
basis of our comparison.
Results
A total of 176 patients underwent closure of ASD. Eightyone patients for device closure and 95 patients for surgery
satisfied the inclusion criteria and were included as
subjects in each arm of study. The median age at operation
for the device group was comparatively higher, 24.0 years
(range 0.5-68 years) while of the surgery group was 14.0
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years (range 1.1 -61 years). A comparison of demographic
and preoperative variables is illustrated in Table 1.
Comparison of Closure Results
The device group consisted of 81 patients, 32 males (39.5%)
and 49 females (60.5%).Of the 81 patients, 78 had devices
successfully deployed (96.3%) across the atrial septum. In
3 (3.7%) of the patients the device embolized soon after
implantation and had to be removed surgically. These
patients will be discussed subsequently. These 3 patients
have been included in both transcatheter and surgical
category since they had an immediate successful closure
but due to embolization were later surgically treated. There
were 11 candidates who had been initially considered
suitable for device closure based on transthoracic
echocardiography. However, device implantation was
not attempted in these subjects since on trans-esophageal
echocardiography the ASD was found to have a deficient
rim (one of either inferior, superior or aortic rim) and were
thus deferred for surgery (the outcome of these patients is
included under the surgical data only). The mean size of
the ASD was 18.9 ± 7.0 mm (range 4 to 33 mm). The mean
size of the amplatzer device was 23.4 ± 6.7 mm (range 8 to
34 mm).The mean fluoroscopy time was 14.5 ± 10.3 min
(range 3.2 to 54 min).
The surgical group consisted of 95 patients, 50 males
(52.6%) and 45 females (47.4%). The size of the defect
ranged from 7 mm to 63 mm, mean 25.2 ± 10.0 mm. The
mean cardiopulmonary bypass time was 58.7 ± 23.4 min
and the aortic cross-clamp time was 32.1 ± 15.3 min. The
mean minimum temperature reached was found to be
35.5 oC. After each surgery, a postoperative on table echo
was done to check for the presence of any hemodynamic
abnormality or for any residual patch defect (significant
>2 mm). After the procedure inotropic support was
provided in 50 (52.6%) cases and consisted of either one
of epinephrine, dopamine, milrinone, dobutamine or a
combination of epinephrine and milrinone.
All but one patient in the surgical group had a successful
closure immediately after the procedure.
A comparison of operative and postoperative outcomes

Table 1. Comparison of demographic and baseline clinical data
between surgical and device closure group
Mean ± SD
Surgical Patients
(n=95)

Device Patients
(n=81)

Height (cm)

130.9 ± 37.3

141.8 ± 26.5

Weight (kg)

40.0 ± 29.1

44.0 ± 21.6

Age (years)

18.8 ± 16.7

23.3 ± 16.4

14

3

14

7

24.7 ± 9.9

18.9 ± 7.0

Patients with family
history of ASD
Pulmonary Hypertension
(on admission)
Size of ASD (mm)
ASD: atrial septum defect

between the two groups is demonstrated in Table 2.
Comparison of ICU, Hospital Stay and Procedure Cost
In the device group all patients were shifted immediately
after percutaneous closure from the cardiac catheterization
laboratory to the wards. In contrast all surgical patients
were required to be in the intensive care unit for at least
one day.
The mean length of inpatient stay for the surgical group
was 5.0 ± 2.7 days. This was longer than the patients of
device group 3.0 ± 0.4 days.
The mean cost per successful closure procedure was
around USD $300 higher for the device. Although the cost
of radiology and laboratory investigations was higher in
the surgical group the high cost of the Amplatzer device
(currently USD $2500) weighted much heavier on the
overall total charges despite patients in this group had a
shorter hospital stay.
Comparison of Complications
There were complications observed in both surgical and
device closure patients. Table 3 summarizes the major
complications encountered between the two groups.
In the surgery group there were two patients of each
pleural effusion and pneumothorax. These were treated
via mechanical drainage and developed no further

Table 2. Comparison of operative and postoperative outcomes between surgical and device closure group
Mean ± SD
Surgical Patients (n=95)

Device Patients (n=81)

Duration of Surgery/Procedure (min)

168.3 ± 38.1

64.2 ± 29.0

CPB Time/Fluoroscopy Time (min)

58.7 ± 23.4

14.5 ± 10.3

Aortic Cross-Clamp Time (min)

32.1 ± 15.3

-

Mean Minimum Temperature (oC)

35.5 ± 1.8

-

Length of CICU stay (days)

1.5 ± 1.1

Length of hospital stay (days)

5.0 ± 2.7

3.0 ± 0.4

0

0

Residual ASDs (≥2 mm)
On table deferred for surgery
Total procedure success (%)
Mean total cost (USD $)

-

0

11

100

96.3

2460.90 ± 443.57

2764.61 ± 528.07

ASD: atrial septum defect; CPB: cardiopulmonary bypass time
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Table 3. Comparison of major complications between surgical
and device closure group
Surgical
Patients (n=95)

Device Patients
(n=81)

13.7

7.4

4

0

Pneumonia

1

0

Pericardial Effusion
(requiring tube
thoracostomy)

0

0

Pleural Effusion (requiring
tube thoracostomy)

2

0

Pneumothorax (requiring
tube thoracostomy)

2

0

Reopening

1

0

Device Embolization

0

3

Device Endocarditis

-

0

4

3

3

1

Morbidity
Complications (%)
[on patient-basis]
Wound Infections/Groin
Hematoma

Arrhythmias (requiring
medication)
Readmission within 30
days)

complication. There was an immediate early surgical
wound complication in one patient requiring sternal
wire removal and antibiotic treatment. There was one
patient which required a reopening, due to misdirection
of the IVC to the left atrium resulting in post-operative
desaturation. The patient was taken back to surgery and
the ASD was closed with IVC draining into the right
atrium. There were 3 readmissions within 30 days which
were due to superficial wound infection. The mean time
for follow-up in the surgical group was 6.8±9.6 months.
Of the 95 patients only 8 (8.4%) were in NYHA II on
follow-up and the rest were in NYHA I.
In comparison, patients in device group had a much
lower rate of complication. Device embolization requiring
surgical retrieval was the most major complication
and occurred in 3 patients, shortly after the procedure.
Cardiac arrhythmia was a common minor complication
of both groups occurring in 3 patients in device group and
4 patients in the surgery group. These were brief episodes
and were resolved by the use of medication. There were
no cases of vascular complication (groin hematoma) in
patients treated by cardiac intervention. There was one
patient who was readmitted due to non-cardiac reasons.
There were no deaths in either the device or surgical group
and all patients were discharged in stable conditions from
the hospital.
Of the 3 devices that were dislodged, one of them was
a 16 year old girl who developed premature ventricular
contractions shortly after the procedure. Echocardiogram
and fluoroscopy revealed the device to be in the right
ventricle near the tricuspid valve requiring immediate
surgical retrieval. The second was a 53-year-old female.
Her pre-discharge echo showed an ASD and fluoroscopy
208
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revealed the device in the left ventricle. The last case
was a 16-year-old boy who experienced post-operative
palpitations. Echocardiogram revealed the device to be
dislodged in right ventricular outflow tract. All these
patients were immediately operated surgically. The
defect was closed using an autologous pericardial patch
and postoperative echo showed no residual ASD. All of
them made a smooth postoperative recovery and were
discharged in stable conditions. On follow-up (2 years, 2
years and 3.5 months) they were asymptomatic and there
was no residual ASD demonstrated by echocardiography.
The mean time for follow-up for this group was 10.8 ±
15.9 months. Out of the 81 patients only 5 (6.2%) were in
NYHA II while the rest were in NYHA I.
Discussion
ASDs account for 10% of all cardiac malformations in
childhood.1 If left uncorrected, they may lead to premature
death from congestive cardiac failure.15 Patients with ASD
and left to right shunts are at increased risk of developing
pulmonary arterial hypertension.16 As seen in our data 21
patients (14 in surgical and 7 in device patients), both of
pediatric and adult age group had developed pulmonary
hypertension at the time of presentation. These were
echocardiographic findings and the outcome of these
patients improved after treatment.
ASD has been surgically repaired for almost 60 years.17
However in recent years the transcatheter approach
to occlude secundum ASD has gained considerable
popularity. The main advantages of device include: the
self-centering mechanism, leading to better complete
closure rates; delivery through relatively small introducing
sheaths; and simple placement technique and retrievability
before release. In addition, there are fewer complications,
avoidance of sternotomy and cardiopulmonary bypass,
shorter hospital stay, reduced need for blood products and
less patient discomfort.
This retrospective study describes the advantages and
complications of each technique. Regardless of the
method the mortality in both groups was found to be
zero. However, one of the main finding of our study was
that the morbidity was higher in surgical group compared
to the device group. This finding is in accordance with
other studies.18,19 Although age was not a considered a
criterion for selection for either procedure, patients in
the surgical group were relatively much younger and had
comparatively larger size of defects which could have
attributed to the complications.
Despite the fact that device closure tends to have fewer
complications, embolization is a potentially feared one
which requires immediate surgical intervention for
retrieval and correction of defect.20 In our institution this
complication cannot be attributed by our learning curve
since it occurred late in the course, after implantation of
more than 50 devices.
The 11 patients that were initially assessed to be suitable
for device closure on transthoracic echocardiography
but in the cardiac catheterization lab, on transesophageal
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echocardiography they were found to have a deficient rim.
One may question as why we did not do a TEE earlier.
The reason is being that a TEE is much more expensive
than TTE and requires the patient to undergo general
anesthesia. This is a significant financial concern in a
third world country like Pakistan and hence in our initial
evaluation, TTE is used as the primary diagnostic tool.
In our study, on follow-up in the device group there were
no patients who developed device endocarditis which has
been described as a late complication of this procedure.21
Our analysis revealed that mean surgical closure of ASD
was USD $ 2460.90 ± 443.57 while of the device group was
$ 2764.61 ± 528.07 (these costs are inclusive of all expenses:
cost of device/cardiopulmonary bypass, laboratory,
pharmaceutical and radiology charges, operating room
costs etc.) revealing surgery to be 12.3% cheaper. This is
in correlation with another study by Quek et al24 where
the mean cost per successful procedure was considerably
higher for the device group. The difference is largely due
to the high cost of the device. Other devices might be
cheaper and may lead to a lower cost of the transcatheter
procedure but only the Amplatzer was used in our setting.
Nevertheless, there is less utilization of beds and ICU
facilities which reduces load on hospital resources and
ancillary staff.
The monetary difference is significantly important in
a low-income country like Pakistan where health care
resources are limited and funds must be allocated in a way
which allows more number of patients to be effectively
treated.
Clinical Implication
In our study device closure of ASD seems comparable to
surgery when the anatomy of the ASD is suitable. Device
closure technique requires a shorter hospital stay implying
early resumption of school or work. Surgical closure is of
course possible for all sizes and anatomical variants of
ASDs. Open heart surgery has its inherent risk associated
but the incidence of major complications (device failure
and embolization) are the same in the two groups.
Limitations
The study had some limitations. When both techniques
were available, patients treated surgically were those with
multiple or more complex defects. This could impact on
the occurrence of complications.
The sample size of the study population was small and this
was a single-center study, so the results are limited to our
own experience.
Conclusion
We conclude that in experienced hands, transcatheter ASD
closure provides comparable results to surgery though
with a shorter hospital stay. However, device closure of
ASD should only be done in centers where an immediate
surgical backup is available. This is the first study of its
kind evaluating outcomes and costs from Pakistan.
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